Welcome to our dedicated page for Groove Botanical news (Ticker: GRVE), a resource for investors and traders seeking the latest updates and insights on Groove Botanical stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Groove Botanical's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Groove Botanical's position in the market.
Groove Botanicals, Inc. (OTC: GRVE) has completed audits for fiscal years ending March 2021 and March 2022 and filed a Form 10 registration statement with the SEC. This move aims to enhance transparency and accountability, allowing the company to potentially uplist to OTCQB or OTCQX. Additionally, Groove announced the divestment of two subsidiaries, focusing on renewable energy and EV battery technologies. These actions are expected to strengthen shareholder value and align with the company's new business model in sustainable technologies.
Groove Botanicals, Inc. (OTC: GRVE) has engaged CPA firm TAAD, LLP to audit its financial statements for FY 2020 and 2021. This move aims to enhance transparency and investor confidence by ensuring accurate financial reporting. The audits are expected to conclude by March 2022, facilitating Groove's transition to a fully reporting public company on OTC Markets. President Kent Rodriguez emphasized that TAAD's expertise will support Groove's public listing goals and commitment to health-oriented consumer products, including CBD and plant-based extracts.
FAQ
What is the current stock price of Groove Botanical (GRVE)?
What is the market cap of Groove Botanical (GRVE)?
